Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.


There has been a steep interest and investment in AI/ML projects in recent years. Success stories are regularly touted, but in between each win there several failures. With so many AI/ML use-cases left unexplored, how can AI/ML realistically deliver value?
Having a clear understanding of use cases, factors that contribute to failure, and factors that lead to success, will help demystify the pathway to long-term value realization. Furthermore, treating AI/ML as a means within a much larger arsenal will provide perspective on how to permeate AI/ML into the fabric of your organization.
Join our upcoming webinar on October 13,and hear IQVIA’s Associate Directors in Data Sciences Mina Labib and Ruomei Li as they sets out to demystify AI and ML in data management. Sign up now, and learn how to optimize your workflow using data management ML.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Improve the performance of your clinical trials with the power of the IQVIA CORE.
Ensure you have access to insights early with connected devices and clean, analysis-ready data